COLTENE : Annual General Meeting – shareholders approve all motions of the Board of Directors

Media release

Altstätten, March 31, 2021

Annual General Meeting - shareholders approve all motions of the Board of Directors

The Annual General Meeting of COLTENE Holding AG approved all motions of the Board of Directors with a large majority. The shareholders approved the management report, financial statements and consolidated statements 2020, as well as the profit to be carried forward to 2021. They also approved the distribution of CHF 3.00 per share from capital contribution reserves with foreign reference. The Annual General Meeting appointed Nick Huber (Chairman), Erwin Locher, Jürgen Rauch, Matthew Robin, Astrid Waser, Roland Weiger and Allison Zwingenberger as Board members for another term of one year. Ernst & Young AG, St. Gallen, was confirmed as the auditor. Lastly, the shareholders also approved the proposed amendment to the Articles of Incorporation as well as the Compensation Report 2020 a consultative vote, and approved the compensation of the members of the Board of Directors and Group Management.

As in the previous year, the Board of Directors regrets that due to the ongoing coronavirus pandemic, the Annual General Meeting 2021 had to be held without the participation of the shareholders. The shareholders could only exercise their voting rights through the independent proxy.

The distribution of CHF 3.00 corresponds to a yield of 3.5% based on the share price of CHF 86.00 (as of December 31, 2020) and will be paid on April 8, 2021 (payment date). For natural persons residing in Switzerland, this distribution is tax exempt.

Pleasing start to the financial year

In the first quarter of 2021, the COLTENE Group recorded pleasing sales growth that even exceeded the strong first quarter of the previous year. Sales increased not only in the strategic focus area of Infection Control, but a recovery in sales was also seen in the areas of Dental Preservation and Efficient Treatment. However, it is not yet clear whether this is due to catch-up effects or if it reflects a sustainable trend. This, together with continued restrictive spending behavior, had a positive effect on the operating result and net profit of the first three months of the current financial year. The enduring worldwide concerns regarding COVID-19 make it difficult to provide a reliable estimate of future business development.

*****

Page 1 / 2

Financial Calendar
Release of Half-year Report 2021 and	August 6, 2021
Conference call on the half-year results 2021
Release of Annual Report 2021 and	March 4, 2022
Media and analyst conference on 2021 financial year
Annual General Meeting 2022	April 21, 2022
Release of Half-year Report 2022 and	Friday, August 5, 2022
Conference call on the half-year results 2022

Sign up for email updates from COLTENE Holding AG at www.coltene.com.

For further information: Gerhard Mahrle, CFO,

phone [phone], mobile [phone], [e-mail]

About COLTENE

COLTENE is an internationally active developer, manufacturer, and seller of dental consumables and small equipment in the areas of Infection Control, Dental Preservation, and Efficient Treatment. COLTENE has state-of-the-artproduction facilities in the USA, Canada, Germany, France, and Switzerland as well as own distribution organizations in all major markets including Europe, North and Latin America, Japan, China, and India. Dentists and dental labs all around the globe trust COLTENE's high-qualityproducts. The registered shares of COLTENE Holding AG (CLTN) are listed on SIX Swiss Exchange. Learn more about COLTENE and our products at www.coltene.com.

Contact

COLTENE Holding AG

Feldwiesenstrasse 20

9450 Altstätten, Switzerland T + 41 71 757 53 00 [e-mail]

This written statement and oral statements or other statements made, or to be made, by us contain forward-looking statements that do not relate solely to historical or current facts. These forward-looking statements are based on the current plans and expectations of our management and are subject to a number of uncertainties and risks that could significantly affect our current plans and expectations, as well as future results of operations and financial condition. We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Page 2 / 2